At the board meeting held on July 19, 2019, Mr. Jun Chang was appointed as the CEO of the company. Dr. Hun Wi, now the former CEO, will lead the R&D team in charge of performance validation and clinical applications.
At the board meeting held on July 19, 2019, Mr. Jun Chang was appointed as the CEO of the company. Dr. Hun Wi, now the former CEO, will lead the R&D team in charge of performance validation and clinical applications.
